Targeting Chromatin Modulators with Therapeutic Degraders
Time: 1:40 pm
day: Conference Day 1 - PM
Details:
• Applying degradation to achieve selectivity
• Exploration of varying E3 ligase activity
• Expanding degrader delivery and formulation